Innovative approaches to production of mesenchymal stem cell-derived therapeutics: Unleashing the potential of fixed-bed bioreactors

Wednesday, March 20, 2024 at 2:20 PM to 2:40 PM · 20 min. (Europe/London)
Cell Therapy Manufacturing [Track 10]
Presentation
Univercells Technologies
59
Univercells Technologies by Donaldson is a global provider of innovative biomanufacturing technologies to achieve cost-effective viral production from R&D to commercial scales. The company offers a comprehensive technology portfolio leveraging the strengths of process intensification and chaining as a direct answer to the growing demand of viral vectors and viral vaccines. Univercells Technologies by Donaldson is committed to helping customers increase performance with minimized footprint and costs today, while anticipating the needs of tomorrow. Building upon years of expertise and capitalizing on technology vetted by world leaders, Univercells Technologies by Donaldson was incorporated in Belgium in 2020 and is now part of Donaldson Company.

Registered attendees

Emmanuelle Cameau
Emmanuelle Cameau
Scientific Director Viral VectorsCytiva
Farhad Chariyev-Prinz
Farhad Chariyev-Prinz
PostdocUniversity of Natural Resources and Life Sciences, Vienna
Isaak Decoene
Isaak Decoene
Postdoctoral researcherKU Leuven

Log in

See all the content and easy-to-use features by logging in or registering!